TRVI Trevi Therapeutics, Inc. - Common Stock
NASDAQ · Pharmaceuticals · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 6, 2026
$13,91
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$9,2852-Wochen-Tief
$20,2252-Wochen-Hoch
Marktkapitalisierung (MRQ)
$1.98B
P/E
-43.5
EPS
$-0.32
Ihre Abzeichen
52W-Spanne
$9–$20
Analystenbewertung
BUY
Kursziel
$28
P/E
-43.5
ROE
-22.4%
Nettogewinnmarge
·
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
TRVI Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$13.91
Marktkapitalisierung (MRQ)
$1.98B
P/E
-43.5
EPS
$-0.32
ROE
-22.4%
52W-Spanne
$9–$20
TRVI Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
EPS$-0.322021-12-31 → 2025-12-31
Freier Cashflow$-42M2019-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | TRVI | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -43.55-Jahres-Durchschnitt ≈-11.5 | ≈-11.5 | · | · | |
| K/B (MRQ) | 6.25-Jahres-Durchschnitt ≈3.2 | ≈3.2 | 3.4 | Überbewertet | |
| Kurs / FCF (TTM) | -37.55-Jahres-Durchschnitt ≈-13.8 | ≈-13.8 | · | · | |
| Kurs / Cashflow (TTM) | -37.65-Jahres-Durchschnitt ≈-11.2 | ≈-11.2 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 9.75-Jahres-Durchschnitt ≈3.2 | ≈3.2 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | TRVI | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| ROA | -28.1%5-Jahres-Durchschnitt ≈-43.7% | ≈-43.7% | -3.6% | Schwach | |
| ROE | -22.4%5-Jahres-Durchschnitt ≈-76.4% | ≈-76.4% | -16.4% | Unterdurchschnittlich | |
| ROIC | -26.9%5-Jahres-Durchschnitt ≈-67.5% | ≈-67.5% | -10.3% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | TRVI | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 37.35-Jahres-Durchschnitt ≈11.4 | ≈11.4 | 4.7 | Starke Liquidität | |
| Quick Ratio | 19.35-Jahres-Durchschnitt ≈11.1 | ≈11.1 | 3.4 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
13.7%
Nächster Bericht
Nov 11, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 5, 2026 | $-0.11 | $-0.11 | 2.2% |
| 31. März 2026 | $-0.09 | $-0.08 | -15.4% | |
| 31. Dezember 2025 | $-0.06 | $-0.10 | 40.1% | |
| 30. September 2025 | $-0.08 | $-0.10 | 20.2% | |
| 30. Juni 2025 | $-0.09 | $-0.10 | 12.6% | |
| 31. März 2025 | $-0.09 | $-0.12 | 27.1% | |
| 31. Dezember 2024 | $-0.11 | $-0.12 | 9.3% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $33M | $39M | $24M | $20M | $23M | $22M | $19M | $14M | |
| SG&A Expense | $16M | $12M | $10M | $10M | $9M | $10M | $7M | $4M | |
| Operating Expenses | $49M | $52M | $34M | $30M | $32M | $32M | $27M | $18M | |
| Operating Income | $-49M | $-52M | $-34M | $-30M | $-32M | $-32M | $-27M | $-18M | |
| Interest Expense | · | · | $391.0K | $1M | $1M | $456.0K | · | $174.0K | |
| Interest Income | $7M | $4M | $5M | · | · | · | · | · | |
| Other Non-op | $-31.0K | $-15.0K | $469.0K | $289.0K | $-375.0K | $-287.0K | $577.0K | $-2M | |
| Pretax Income | $-43M | $-48M | $-29M | $-29M | $-34M | $-33M | $-26M | $-21M | |
| Income Tax | $-64.0K | $-30.0K | $-32.0K | $-36.0K | $-21.0K | $-18.0K | $-18.0K | $-124.0K | |
| Net Income | $-43M | $-48M | $-29M | $-29M | $-34M | $-33M | $-26M | $-21M | |
| EPS (Basic) | $-0.32 | $-0.47 | $-0.29 | $-0.45 | $-1.49 | · | · | · | |
| EPS (Diluted) | $-0.32 | $-0.47 | $-0.29 | $-0.45 | $-1.49 | · | · | · | |
| Shares (Basic) | 134,747,198 | 101,971,873 | 99,033,373 | 64,541,911 | 22,841,481 | · | · | · | |
| Shares (Diluted) | 134,747,198 | 101,971,873 | 99,033,373 | 64,541,911 | 22,841,481 | · | · | · | |
| EBITDA | $-49M | $-51M | $-34M | $-30M | $-32M | $-32M | $-27M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $34M | $32M | $13M | $37M | $45M | $57M | $7M | |
| Short-term Investments | $169M | $74M | $51M | $108M | · | · | · | · | |
| Prepaid Expense | $1M | $939.0K | $4M | $795.0K | $886.0K | $1M | $2M | $1M | |
| Other Current Assets | $2M | $867.0K | $955.0K | $1M | $241.0K | $265.0K | · | · | |
| Current Assets | $192M | $109M | $88M | $123M | $38M | $46M | $60M | $9M | |
| PP&E (Net) | $178.0K | $157.0K | $216.0K | $170.0K | $53.0K | $103.0K | $118.0K | $149.0K | |
| PP&E (Gross) | $537.0K | $385.0K | $350.0K | $395.0K | $235.0K | $235.0K | $203.0K | $195.0K | |
| Accum. Depreciation | $359.0K | $228.0K | $134.0K | $225.0K | $182.0K | $132.0K | $85.0K | $46.0K | |
| Other Non-current Assets | $928.0K | $243.0K | $297.0K | $205.0K | $334.0K | $532.0K | · | · | |
| Total Assets | $193M | $111M | $89M | $123M | $38M | $47M | $60M | $11M | |
| Accounts Payable | $4M | $3M | $2M | $3M | $3M | $2M | $2M | $603.0K | |
| Accrued Liabilities | $6M | $7M | $4M | $4M | $4M | $3M | $4M | $2M | |
| Current Liabilities | $10M | $11M | $6M | $13M | $13M | $6M | $5M | $3M | |
| Capital Leases | $446.0K | $747.0K | $1M | $2.0K | $24.0K | $144.0K | $257.0K | $46.0K | |
| Other Non-current Liabilities | · | · | · | $3.0K | · | · | · | · | |
| Total Liabilities | $10M | $11M | $7M | $16M | $21M | $20M | · | · | |
| Common Stock | $128.0K | $94.0K | $68.0K | $60.0K | $29.0K | $19.0K | $18.0K | $4.0K | |
| Paid-in Capital | $513M | $387M | $322M | $318M | $198M | $174M | $169M | · | |
| Retained Earnings | $-330M | $-287M | $-239M | $-210M | $-181M | $-147M | $-114M | $-109M | |
| AOCI | $148.0K | $61.0K | $-29.0K | $-122.0K | · | · | · | · | |
| Stockholders' Equity | $183M | $100M | $83M | $107M | $17M | $27M | $55M | $-109M | |
| Liabilities + Equity | $193M | $111M | $89M | $123M | $38M | $47M | $60M | $11M | |
| Shares Outstanding | 128,306,056 | 93,602,631 | 68,283,699 | 59,943,430 | 28,505,804 | 18,546,786 | 17,834,570 | 438,600 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $144.0K | $147.0K | $123.0K | $43.0K | · | · | · | · | |
| Stock-based Comp | $5M | $4M | $2M | $2M | $3M | $2M | $1M | $496.0K | |
| Other Non-cash | $-5M | $6M | $-5M | · | · | · | · | · | |
| Operating Cash Flow | $-42M | $-38M | $-32M | $-28M | $-29M | $-29M | $-23M | $-18M | |
| CapEx | $12.0K | $35.0K | $137.0K | $159.0K | · | $32.0K | $9.0K | $158.0K | |
| Investing Cash Flow | $-94M | $-22M | $59M | $-107M | · | $-32.0K | $-9.0K | $-158.0K | |
| Debt Issued | · | · | · | · | · | $14M | · | · | |
| Net Debt Issued | · | · | · | $-6M | · | $14M | · | · | |
| Financing Cash Flow | $121M | $61M | $-8M | $111M | $21M | $17M | $73M | $4M | |
| Net Change in Cash | $-15M | $2M | $20M | $-24M | $-8M | $-12M | $50M | $-15M | |
| Taxes Paid | $-33.0K | $-32.0K | · | · | · | · | · | · | |
| Free Cash Flow | $-42M | $-38M | $-32M | $-28M | · | $-29M | $-23M | · | |
| Levered FCF | · | · | $-32M | $-29M | · | $-29M | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROA | -28.1% | -47.8% | -27.4% | -36.1% | -79.3% | -61.2% | -73.9% | · | |
| ROE | -22.4% | -60.4% | -33.8% | -26.8% | -238.5% | -104.2% | -45.2% | · | |
| ROIC | -26.9% | -51.7% | -41.0% | -27.8% | -190.1% | -119.0% | -48.8% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 19.7 | 10.4 | 15.0 | 9.2 | 3.0 | 8.3 | 11.5 | · | |
| Quick Ratio | 19.3 | 10.2 | 14.2 | 9.0 | 2.9 | 8.1 | 11.0 | · | |
| Interest Coverage | · | · | -86.8 | -25.7 | -27.0 | -71.2 | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.43 | $1.06 | $1.21 | $1.79 | $0.60 | $1.47 | $3.06 | · | |
| Cash Flow / Share | $-0.31 | $-0.38 | $-0.32 | $-0.44 | · | · | · | · | |
| Cash / Share | $0.15 | $0.36 | $0.47 | $0.21 | $1.29 | $2.43 | $3.21 | · | |
| EPS (TTM) | $-0.32 | $-0.47 | $-0.29 | $-0.45 | $-1.49 | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-43M | $-48M | $-29M | $-29M | $-34M | $-33M | $-26M | · | |
| Market Cap | $1.61B | $386M | $92M | $116M | $22M | $45M | $67M | · | |
| P/E | -39.1 | -8.8 | -4.6 | -4.3 | -0.5 | · | · | · | |
| P/B | 8.8 | 3.9 | 1.1 | 1.1 | 1.3 | 1.6 | 1.2 | · | |
| P / Tangible Book | 8.8 | 3.9 | 1.1 | 1.1 | 1.3 | 1.6 | · | · | |
| P / Cash Flow | -38.2 | -10.1 | -2.9 | -4.1 | -0.8 | -1.5 | -2.9 | · | |
| P / FCF | -38.2 | -10.1 | -2.9 | -4.1 | · | -1.5 | -2.9 | · | |
| Earnings Yield | -2.6% | -11.4% | -21.6% | -23.3% | -190.5% | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $15M | $10M | $6M | $10M | $9M | $8M | $9M | $11M | $10M | $9M | $7M | $6M | $6M | $5M | $4M | $6M | |
| SG&A Expense | $5M | $5M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $2M | $3M | |
| Operating Expenses | $21M | $15M | $10M | $14M | $14M | $11M | $12M | $14M | $13M | $12M | $9M | $9M | $8M | $8M | $7M | $8M | |
| Operating Income | $-21M | $-15M | $-10M | $-14M | $-14M | $-11M | $-12M | $-14M | $-13M | $-12M | $-9M | $-9M | $-8M | $-8M | $-7M | $-8M | |
| Interest Expense | · | · | · | · | · | · | · | · | $1.0K | $1.0K | · | $3.0K | $153.0K | $231.0K | $274.0K | $292.0K | |
| Interest Income | $3M | $2M | $2M | $2M | $1M | $1M | $843.0K | $826.0K | $935.0K | $998.0K | $1M | $1M | · | · | · | · | |
| Other Non-op | $-3.0K | $4.0K | $-16.0K | $-2.0K | $-7.0K | $-6.0K | $2.0K | $-11.0K | $-5.0K | $-1.0K | $-3.0K | $154.0K | $153.0K | $165.0K | $702.0K | $132.0K | |
| Pretax Income | $-18M | $-13M | $-8M | $-12M | $-12M | $-10M | $-11M | $-13M | $-12M | $-11M | $-8M | $-8M | $-7M | $-6M | $-6M | $-8M | |
| Income Tax | $-19.0K | $-20.0K | $-17.0K | $-15.0K | $-21.0K | $-11.0K | $17.0K | $-31.0K | $-8.0K | $-8.0K | $18.0K | $-13.0K | $-30.0K | $-7.0K | $-20.0K | $-7.0K | |
| Net Income | $-18M | $-13M | $-8M | $-12M | $-12M | $-10M | $-11M | $-13M | $-12M | $-11M | $-8M | $-8M | $-7M | $-6M | $-6M | $-8M | |
| EPS (Basic) | $-0.11 | $-0.09 | $-0.06 | $-0.08 | $-0.09 | $-0.09 | $-0.11 | $-0.13 | $-0.12 | $-0.11 | $-0.08 | $-0.08 | $-0.07 | $-0.06 | $0.05 | $-0.12 | |
| EPS (Diluted) | $-0.11 | $-0.09 | $-0.06 | $-0.08 | $-0.09 | $-0.09 | $-0.11 | $-0.13 | $-0.12 | $-0.11 | $-0.08 | $-0.08 | $-0.07 | $-0.06 | $0.05 | $-0.12 | |
| Shares (Basic) | 156,602,158 | 145,592,901 | · | 145,104,986 | 130,350,391 | 117,610,750 | · | 101,282,228 | 101,041,573 | 99,517,212 | · | 99,325,540 | 98,698,579 | 98,610,671 | · | 68,898,810 | |
| Shares (Diluted) | 156,602,158 | 145,592,901 | · | 145,104,986 | 130,350,391 | 117,610,750 | · | 101,282,228 | 101,041,573 | 99,517,212 | · | 99,325,540 | 98,698,579 | 98,610,671 | · | 68,898,810 | |
| EBITDA | $-21M | $-15M | · | $-14M | $-14M | $-11M | · | $-14M | $-13M | $-12M | · | $-9M | $-8M | $-8M | · | $-8M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $54M | $19M | $19M | $57M | $117M | $19M | $34M | $16M | $13M | $14M | $32M | $26M | $14M | $12M | $13M | $67M | |
| Short-term Investments | $265M | $152M | $169M | $138M | $87M | $84M | $74M | $49M | $57M | $59M | $51M | $63M | $80M | $100M | $108M | $59M | |
| Prepaid Expense | $4M | $2M | $1M | $1M | $2M | $2M | $939.0K | $1M | $2M | $3M | $4M | $4M | $3M | $1M | $795.0K | $1M | |
| Other Current Assets | $3M | $2M | $2M | $2M | $2M | $834.0K | $867.0K | $667.0K | $830.0K | $721.0K | $955.0K | $1M | $2M | $2M | $1M | $421.0K | |
| Current Assets | $326M | $176M | $192M | $198M | $207M | $106M | $109M | $67M | $72M | $77M | $88M | $94M | $99M | $114M | $123M | $127M | |
| PP&E (Net) | $336.0K | $265.0K | $178.0K | $213.0K | $239.0K | $277.0K | $157.0K | $174.0K | $198.0K | $204.0K | $216.0K | $238.0K | $225.0K | $245.0K | $170.0K | $68.0K | |
| PP&E (Gross) | · | · | $537.0K | · | · | · | $385.0K | · | · | · | $350.0K | · | · | · | $395.0K | · | |
| Accum. Depreciation | · | · | $359.0K | · | · | · | $228.0K | · | · | · | $134.0K | · | · | · | $225.0K | · | |
| Other Non-current Assets | $4M | $3M | $928.0K | $103.0K | $68.0K | $241.0K | $243.0K | $256.0K | $273.0K | $311.0K | $297.0K | $297.0K | $68.0K | $225.0K | $205.0K | $922.0K | |
| Total Assets | $331M | $180M | $193M | $199M | $208M | $107M | $111M | $69M | $74M | $79M | $89M | $96M | $101M | $116M | $123M | $128M | |
| Accounts Payable | $3M | $2M | $4M | $3M | $3M | $1M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $3M | $2M | |
| Accrued Liabilities | $5M | $5M | $6M | $6M | $6M | $5M | $7M | $7M | $5M | $3M | $4M | $4M | $3M | $3M | $4M | $5M | |
| Current Liabilities | $9M | $7M | $10M | $9M | $9M | $7M | $11M | $9M | $7M | $5M | $6M | $5M | $5M | $13M | $13M | $15M | |
| Capital Leases | $276.0K | $364.0K | $446.0K | $527.0K | $605.0K | $681.0K | $747.0K | $816.0K | $884.0K | $949.0K | $1M | $1M | $1M | $1M | $2.0K | $2.0K | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $3.0K | $15.0K | |
| Total Liabilities | $9M | $7M | $10M | $10M | $10M | $8M | $11M | $10M | $8M | $6M | $7M | $6M | $6M | $14M | $16M | $18M | |
| Common Stock | $142.0K | $128.0K | $128.0K | $128.0K | $122.0K | $100.0K | $94.0K | $75.0K | $73.0K | $69.0K | $68.0K | $64.0K | $63.0K | $60.0K | $60.0K | $58.0K | |
| Paid-in Capital | $683M | $515M | $513M | $511M | $508M | $397M | $387M | $334M | $329M | $322M | $322M | $321M | $319M | $318M | $318M | $315M | |
| Retained Earnings | $-361M | $-343M | $-330M | $-321M | $-310M | $-297M | $-287M | $-276M | $-262M | $-250M | $-239M | $-231M | $-224M | $-216M | $-210M | $-205M | |
| AOCI | $-425.0K | $-190.0K | $148.0K | $30.0K | $24.0K | $73.0K | $61.0K | $139.0K | $-84.0K | $-67.0K | $-29.0K | $-217.0K | $-248.0K | $-88.0K | $-122.0K | $-263.0K | |
| Stockholders' Equity | $322M | $172M | $183M | $190M | $198M | $99M | $100M | $59M | $66M | $72M | $83M | $90M | $95M | $102M | $107M | $110M | |
| Liabilities + Equity | $331M | $180M | $193M | $199M | $208M | $107M | $111M | $69M | $74M | $79M | $89M | $96M | $101M | $116M | $123M | $128M | |
| Shares Outstanding | 142,420,883 | 128,411,048 | 128,306,056 | 128,215,113 | 121,775,753 | 99,892,915 | 93,602,631 | 75,454,375 | 72,591,917 | 68,960,167 | 68,283,699 | 63,855,330 | 63,098,455 | 60,065,408 | 59,943,430 | 58,322,517 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $34.0K | $34.0K | $31.0K | $38.0K | $38.0K | $37.0K | $38.0K | $36.0K | $38.0K | $35.0K | $35.0K | $35.0K | $34.0K | $19.0K | $15.0K | $9.0K | |
| Stock-based Comp | $3M | $2M | $1M | $1M | $1M | $1M | $916.0K | $822.0K | $1M | $723.0K | $609.0K | $530.0K | $530.0K | $578.0K | $501.0K | $569.0K | |
| Other Non-cash | · | $-6M | · | · | · | $-4M | · | · | · | $-323.0K | · | · | · | $-2M | · | · | |
| Operating Cash Flow | $-17M | $-17M | $-8M | $-11M | $-10M | $-13M | $-10M | $-10M | $-9M | $-10M | $-6M | $-7M | $-10M | $-8M | $-6M | $-9M | |
| CapEx | $124.0K | $102.0K | $0 | $12.0K | · | · | $7.0K | $0 | · | · | $22.0K | $18.0K | $40.0K | $57.0K | $116.0K | · | |
| Investing Cash Flow | $-112M | $17M | $-31M | $-51M | $-3M | $-10M | $-24M | $8M | $3M | $-8M | $13M | $18M | $20M | $9M | $-48M | $-5M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $-2M | · | · | |
| Financing Cash Flow | $164M | $222.0K | $284.0K | $2M | $110M | $9M | $51M | $5M | $5M | $-28.0K | $-54.0K | $2M | $-8M | $-2M | $652.0K | $55M | |
| Net Change in Cash | $35M | $498.0K | $-38M | $-60M | $98M | $-15M | $18M | $3M | $-848.0K | $-19M | $6M | $12M | $2M | $-938.0K | $-54M | $42M | |
| Free Cash Flow | · | $-17M | · | · | · | · | · | · | · | · | · | · | · | $-8M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | $-8M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -6.6% | -9.2% | · | -8.8% | -8.7% | -11.1% | · | -16.1% | -14.1% | -11.2% | · | -6.9% | -7.8% | -8.7% | · | -10.3% | |
| ROE | -6.9% | -9.7% | · | -9.5% | -9.3% | -12.0% | · | -17.8% | -15.3% | -12.5% | · | -7.7% | -9.2% | -11.4% | · | -13.6% | |
| ROIC | -6.4% | -8.6% | · | -7.3% | -6.9% | -11.5% | · | -23.8% | -20.1% | -16.4% | · | -10.1% | -8.8% | -7.4% | · | -7.6% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 37.3 | 24.8 | · | 21.9 | 22.4 | 15.4 | · | 7.4 | 10.7 | 14.6 | · | 18.2 | 21.1 | 8.7 | · | 8.7 | |
| Quick Ratio | 36.5 | 24.1 | · | 21.6 | 22.1 | 15.0 | · | 7.2 | 10.3 | 13.8 | · | 17.2 | 20.0 | 8.4 | · | 8.6 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -13289.0 | -11906.0 | · | -3015.0 | -54.8 | -32.7 | · | -28.8 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.26 | $1.34 | · | $1.48 | $1.63 | $1.00 | · | $0.78 | $0.91 | $1.05 | · | $1.40 | $1.51 | $1.69 | · | $1.88 | |
| Cash Flow / Share | · | $-0.11 | · | · | · | $-0.11 | · | · | · | $-0.11 | · | · | · | $-0.08 | · | · | |
| Cash / Share | $0.38 | $0.15 | · | $0.44 | $0.96 | $0.19 | · | $0.21 | $0.18 | $0.20 | · | $0.41 | $0.22 | $0.19 | · | $1.14 | |
| EPS (TTM) | $-0.34 | $-0.32 | · | $-0.37 | $-0.42 | $-0.45 | · | $-0.44 | $-0.39 | $-0.34 | · | $-0.16 | $-0.20 | $-0.27 | · | $-0.74 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-51M | $-46M | · | $-46M | $-47M | $-47M | · | $-44M | $-39M | $-34M | · | $-27M | $-27M | $-28M | · | $-32M | |
| Market Cap | $2.66B | $1.53B | · | $1.17B | $666M | $628M | · | $252M | $216M | $238M | · | $139M | $151M | $111M | · | $90M | |
| P/E | -54.9 | -37.3 | · | -24.7 | -13.0 | -14.0 | · | -7.6 | -7.6 | -10.1 | · | -13.6 | -11.9 | -6.9 | · | -2.1 | |
| P/B | 8.3 | 8.9 | · | 6.2 | 3.4 | 6.3 | · | 4.3 | 3.3 | 3.3 | · | 1.6 | 1.6 | 1.1 | · | 0.8 | |
| P / Tangible Book | 8.3 | 8.9 | · | 6.2 | 3.4 | 6.3 | · | 4.3 | 3.3 | 3.3 | · | 1.6 | 1.6 | 1.1 | · | 0.8 | |
| P / Cash Flow | · | -91.8 | · | · | · | -46.6 | · | · | · | -22.7 | · | · | · | -13.6 | · | · | |
| Earnings Yield | -1.8% | -2.7% | · | -4.0% | -7.7% | -7.1% | · | -13.2% | -13.1% | -9.9% | · | -7.3% | -8.4% | -14.6% | · | -48.0% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Nettoergebnis | $-43M | $-48M | $-29M | $-29M | $-34M |
| Verwässerte EPS | $-0.32 | $-0.47 | $-0.29 | $-0.45 | $-1.49 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 19.7 | 10.4 | 15.0 | 9.2 | 3.0 |
| Quick Ratio | 19.3 | 10.2 | 14.2 | 9.0 | 2.9 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-42M | $-38M | $-32M | $-28M | · |
Institutionelle Eigentümer (13F) 226 Einreicher · $2.8B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
226
Gehaltener Wert
$2.8B
Neue Positionen
41
Geschlossene Positionen
19
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 41 (-2 vs. Vorquartal) | 19 (-5 vs. Vorquartal) | 89 (+23 vs. Vorquartal) | 61 (-4 vs. Vorquartal) | +13.7M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| NEA Management Company, LLC | $246.594.552 | 13.222.228 | 8,67% | Aktien |
| FMR LLC | $234.296.949 | 12.562.839 | 8,24% | Aktien |
| BlackRock, Inc. | $208.041.234 | 11.155.026 | 7,32% | Aktien |
| Frazier Life Sciences Management, L.P. | $185.370.687 | 9.939.447 | 6,52% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $106.017.642 | 5.684.592 | 3,73% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $103.147.089 | 5.530.675 | 3,63% | Aktien |
| Vivo Capital, LLC | $95.015.558 | 5.094.668 | 3,34% | Aktien |
| VANGUARD GROUP INC | $80.561.880 | 6.434.655 | 2,83% | Aktien |
| Woodline Partners LP | $76.116.860 | 4.081.333 | 2,68% | Aktien |
| Vestal Point Capital, LP | $57.815.000 | 3.100.000 | 2,03% | Aktien |
| MPM BIOIMPACT LLC | $57.322.211 | 3.073.577 | 2,02% | Aktien |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $57.269.301 | 3.070.740 | 2,01% | Aktien |
| STATE STREET CORP | $56.459.425 | 3.027.315 | 1,99% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $54.619.528 | 2.928.068 | 1,92% | Aktien |
| MARSHALL WACE, LLP | $49.872.655 | 2.674.137 | 1,75% | Aktien |
| EVENTIDE ASSET MANAGEMENT, LLC | $49.609.000 | 2.660.000 | 1,74% | Aktien |
| Rubric Capital Management LP | $46.709.167 | 2.504.513 | 1,64% | Aktien |
| Artia Global Partners LP | $41.232.390 | 2.210.852 | 1,45% | Aktien |
| ACORN CAPITAL ADVISORS, LLC | $40.001.341 | 2.144.844 | 1,41% | Aktien |
| First Light Asset Management, LLC | $39.113.060 | 2.097.215 | 1,38% | Aktien |
| Pictet Asset Management Holding SA | $37.557.109 | 2.013.786 | 1,32% | Aktien |
| Logos Global Management LP | $35.062.000 | 1.880.000 | 1,23% | Aktien |
| Affinity Asset Advisors, LLC | $33.573.208 | 1.800.172 | 1,18% | Aktien |
| EMERALD ADVISERS, LLC | $33.525.445 | 1.797.611 | 1,18% | Aktien |
| Siren, L.L.C. | $33.325.070 | 1.786.867 | 1,17% | Aktien |
| Pivotal bioVenture Partners Investment Advisor LLC | $32.500.833 | 1.742.672 | 1,14% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $30.038.753 | 1.610.657 | 1,06% | Aktien |
| VIKING GLOBAL INVESTORS LP | $28.807.611 | 1.544.644 | 1,01% | Aktien |
| BANK OF AMERICA CORP /DE/ | $28.588.381 | 1.532.889 | 1,01% | Aktien |
| Assenagon Asset Management S.A. | $28.447.106 | 1.525.314 | 1,00% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $28.100.554 | 2.355.453 | 0,99% | Aktien |
| ORBIMED ADVISORS LLC | $26.674.964 | 1.430.293 | 0,94% | Aktien |
| Jones Hill Capital LP | $24.976.304 | 1.339.212 | 0,88% | Aktien |
| NAN FUNG TRINITY (HK) LTD | $22.634.013 | 1.213.620 | 0,80% | Aktien |
| EMERALD MUTUAL FUND ADVISERS TRUST | $22.584.497 | 1.210.965 | 0,79% | Aktien |
| GOLDMAN SACHS GROUP INC | $22.426.998 | 1.202.520 | 0,79% | Aktien |
| Soleus Capital Management, L.P. | $21.999.876 | 1.179.618 | 0,77% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $21.948.663 | 1.176.872 | 0,77% | Aktien |
| BARCLAYS PLC | $21.299.737 | 1.142.077 | 0,75% | Aktien |
| Saturn V Capital Management LP | $19.620.602 | 1.052.043 | 0,69% | Aktien |
| FLPUTNAM INVESTMENT MANAGEMENT CO | $19.359.763 | 1.038.057 | 0,68% | Aktien |
| NORTHERN TRUST CORP | $18.762.609 | 1.006.038 | 0,66% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $18.138.990 | 972.600 | 0,64% | Kaufoption |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $18.004.747 | 965.402 | 0,63% | Aktien |
| Candriam S.C.A. | $18.002.647 | 966.219 | 0,63% | Aktien |
| Balyasny Asset Management L.P. | $15.760.873 | 845.087 | 0,55% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $15.685.750 | 841.059 | 0,55% | Aktien |
| MORGAN STANLEY | $14.928.673 | 800.465 | 0,53% | Aktien |
| Nuveen, LLC | $14.270.533 | 765.176 | 0,50% | Aktien |
| Burkehill Global Management, LP | $13.521.250 | 725.000 | 0,48% | Aktien |
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| New Enterprise Associates 16, L.P., NEA Partners 16, L.P., NEA 16 GP, LLC, NEA 18 Venture Growth Equity, L.P., NEA Partners 18 VGE, L.P., NEA 18 VGE GP, LLC, Forest Baskett, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell, Paul Walker ×10 Einreichungen | 7. Mai 2026 | 10,50% | Änderung | Passive Anlage | SEC |
| Omega Fund V, L.P., Omega Fund V GP, L.P., Omega Fund V GP Manager, Ltd., Richard J. Lim, Claudio Nessi, Anne-Mari Paster, Otello Stampacchia | 20. Mai 2019 | · | Erste Einreichung | Vorstandskampagne | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 37 Insider · 13 Führungskräfte · 9 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jennifer L Good | President & CEO | 19. Februar 2026 A | 213.313 | 0 | 0 | $0 |
| David C Hastings | Chief Financial Officer | 8. Januar 2026 A | · | 0 | 0 | $0 |
| Lisa Delfini | Chief Financial Officer | 31. Mai 2025 A | 64.660 | 0 | 0 | $0 |
| Christopher Seiter | Chief Financial Officer | 17. Februar 2021 A | · | 0 | 0 | $0 |
| Farrell Simon | Chief Commercial Officer | 19. Februar 2026 A | 76.900 | 0 | 0 | $0 |
| Christopher Galletta | Controller and Principal Accounting Officer | 19. Februar 2026 A | 26.095 | 0 | 0 | $0 |
| James V Cassella | Chief Development Officer | 19. Februar 2026 A | · | 0 | 0 | $0 |
| Thomas Sciascia | Chief Scientific Officer | 19. Februar 2026 A | 221.373 | 0 | 0 | $0 |
| David J Clark | Chief Medical Officer | 15. Februar 2024 A | · | 0 | 0 | $0 |
| William P Forbes | Chief Development Officer | 29. Juni 2022 A | · | 0 | 0 | $0 |
| Frank P Muscolo | Controller | 17. Februar 2021 A | · | 0 | 0 | $0 |
| Helena Brett-Smith | Chief Development Officer | 13. Februar 2020 A | · | 0 | 0 | $0 |
| Yann Mazabraud | Chief Commercial Officer and Head of International | 13. Februar 2020 A | · | 0 | 0 | $0 |
| Michael Thomas Heffernan | Direktor | 15. September 2026 M | 6.351 | 0 | 4 | $-595.806 |
| David P Meeker | Direktor | 3. Juni 2026 A | 352.489 | 0 | 0 | $0 |
| Edward T. Mathers | Direktor | 3. Juni 2026 A | 948.948 | 0 | 0 | $0 |
| Dominick Colangelo | Direktor | 3. Juni 2026 A | · | 0 | 0 | $0 |
| Anne Vanlent | Direktor | 3. Juni 2026 A | 25.983 | 0 | 0 | $0 |
| Mette Kirstine Agger | Direktor | 9. Mai 2019 C | 1.151.544 | 0 | 0 | $0 |
| Anna Guyer Mitsak | Direktor | 7. Mai 2019 A | · | 0 | 0 | $0 |
| Eran Nadav | Direktor | 7. Mai 2019 A | · | 0 | 0 | $0 |
| Mohamad Makhzoumi | 10%-Eigentümer | 11. April 2022 P | 948.948 | 0 | 0 | $0 |
| Ali Behbahani | 10%-Eigentümer | 11. April 2022 P | 948.948 | 0 | 0 | $0 |
| Anthony A. Florence, Jr. | 10%-Eigentümer | 11. April 2022 P | 948.948 | 0 | 0 | $0 |
| Peter W. Sonsini | 10%-Eigentümer | 11. April 2022 P | 948.948 | 0 | 0 | $0 |
| Paul Walker | 10%-Eigentümer | 11. April 2022 P | 948.948 | 0 | 0 | $0 |
| Forest Baskett | 10%-Eigentümer | 11. April 2022 P | 10.421.428 | 0 | 0 | $0 |
| Scott D. Sandell | 10%-Eigentümer | 11. April 2022 P | 948.948 | 0 | 0 | $0 |
| Joshua Makower | 10%-Eigentümer | 3. April 2020 X | 5.937.998 | 0 | 0 | $0 |
| Debra A Drake | 10%-Eigentümer | 9. Mai 2019 C | 10.399 | 0 | 0 | $0 |
| Richard King Mellon Foundation | 10%-Eigentümer | 9. Mai 2019 C | 347.157 | 0 | 0 | $0 |
| Lundbeckfond Invest A/S | 10%-Eigentümer | 9. Mai 2019 C | 1.151.544 | 0 | 0 | $0 |
| Peter F Drake | 10%-Eigentümer | 9. Mai 2019 C | 62.540 | 0 | 0 | $0 |
| William J Oshea | 10%-Eigentümer | 9. Mai 2019 C | 114.080 | 0 | 0 | $0 |
| David M Mott | 10%-Eigentümer | 9. Mai 2019 C | 4.438.562 | 0 | 0 | $0 |
| Peter J Barris | 10%-Eigentümer | 9. Mai 2019 C | 4.438.562 | 0 | 0 | $0 |
| Carmen Chang | · | 11. April 2022 P | 948.948 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 23 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 1,55% | 17.529 NS | 31. Juli 2026 | N-PORT |
| IHE · iShares Trust | 0,43% | 436.183 SH | 11. September 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,14% | 148.479 SH | 19. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,13% | 10.058 SH | 2. Oktober 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,12% | 114.901 SH | 19. August 2026 | Täglich |
| IWO · iShares Trust | 0,11% | 1.007.147 SH | 11. September 2026 | Täglich |
| IBB · iShares Trust | 0,11% | 707.885 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,06% | 51.308 NS | 31. Juli 2026 | N-PORT |
| ISCG · iShares Trust | 0,06% | 37.734 SH | 11. September 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,06% | 616.796 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,06% | 2.737.721 SH | 11. September 2026 | Täglich |
| ESML · iShares Trust | 0,05% | 81.532 SH | 11. September 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,03% | 287.822 SH | 19. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 45.551 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 1.352.952 SH | 19. August 2026 | Täglich |
| WSML · iShares Trust | 0,01% | 5.214 SH | 11. September 2026 | Täglich |
| TILT · FlexShares Trust | 0,00% | 3.318 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 152.436 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 24.754 SH | 9. September 2026 | Täglich |
| PTH · Invesco Exchange-Traded Fund Trust | 0,00% | 25 SH | 2. Oktober 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 4.048.595 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 8.874 SH | 19. August 2026 | Täglich |
| ISCB · iShares Trust | · | 5.335 SH | 11. September 2026 | Täglich |
TRVI Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 18 Analysten
KAUF
Median-Ziel
$25.00
+79,7%
6 33,3%
Starker Kauf
11 61,1%
Kauf
1 5,6%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
11 Analysten · 2026-09-27Mittelwert-Ziel $28.18 +102,6%
← Unter allen Zielen
Aktueller Preis $13.91
Tief$23.00
Mittelwert$28.18
Hoch$40.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| TRVI | $1.61B | -39.1 | · | · | -22.4% | · |
| HRMY | $2.16B | 13.8 | 21.5% | 18.3% | 19.3% | 77.2% |
| PBH | $3.33B | 15.2 | -4.3% | 17.5% | 10.2% | 54.7% |
| GPCR | $14.78B | -86.9 | · | · | -12.3% | · |
| TRLV | · | · | -0.45% | -10.3% | -10.4% | 60.2% |
| NUVB | $3.03B | -14.9 | 699.0% | -325.3% | -60.3% | · |
| SEPN | $1.25B | -25.3 | 4174.5% | -106.4% | -12.9% | · |
| ANIP | $1.78B | 23.8 | 43.8% | 8.9% | 16.6% | · |
| ETON | $457M | · | 104.9% | -5.8% | -18.4% | 53.5% |
| RAPP | $1.45B | -10.6 | · | · | -29.8% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026